SML0189

Indinavir sulfate salt hydrate

≥98% (HPLC), powder, antiretroviral agent

• Sinônimo(s): 2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide sulfate hydrate, Crixivan hydrate, L-735,524 hydrate, MK-639 hydrate
• Fórmula empírica (Notação de Hill): C₃₆H₄₇N₅O₄·H₂SO₄ · xH₂O
• Peso molecular: 711.87 (anhydrous basis)
• Código UNSPSC: 51111800
• NACRES: NA.77

Propriedades

• Nome do produto: Indinavir sulfate salt hydrate, ≥98% (HPLC)
• Ensaio: ≥98% (HPLC)
• Formulário: powder
• condição de armazenamento: desiccated
• cor: white to tan
• solubilidade: H₂O: ≥15 mg/mL
• originador: Merck & Co., Inc., Kenilworth, NJ, U.S.
• temperatura de armazenamento: 2-8°C

Descrição

Aplicação

Indinavir sulfate salt hydrate may be used in HIV-related cell signaling studies.

Ações bioquímicas/fisiológicas

Indinavir sulfate is an antiretroviral; HIV Protease Inhibitor

Indinavir sulfate is an antiviral HIV protease inhibitor.

Indinavir sulfate suppresses the replication of HIV and is an important component of antiretroviral therapy for initial treatment of HIV infection. It is known to cause renal and urologic toxicity.[1]

Características e benefícios

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable